On the Cutting Edge of HIV Care
PROGRAM DESCRIPTION The past 3 decades have seen considerable advances in antiretroviral (ART) regimens for HIV-infected individuals. Since many ART agents, combinations, and classes are now available, clinicians who treat ...
The past 3 decades have seen considerable advances in antiretroviral (ART) regimens for HIV-infected individuals. Since many ART agents, combinations, and classes are now available, clinicians who treat HIV have myriad options from which to choose. However, each drug class and each individual agent is associated with its own set of advantages and disadvantages. It is critical that clinicians are knowledgeable about these factors, including the effect of HIV drug selection on patient adherence and the drug resistance and safety profiles of each agent. As new therapies for HIV are continually approved and with a growing number of new options on the horizon, clinicians must be aware of how to best utilize each potential regimen in diverse patient populations.This educational activity uses a case-based approach to illustrate how HIV treatment should be tailored to the characteristics and needs of each patient. Considerations for selection of an initial ART regimen will be discussed, as will factors to take into account when managing the care of individuals who develop treatment resistance secondary to poor adherence, and considerations for switching virologically suppressed, treatment-experienced patients to a different regimen.
After completing the activity, the participant should be better able to:Investigate the impact of ART selection on drug resistance, safety, and adherenceReview the updated HHS guidelines for HIV treatment and translate the implications of key changes to actual practiceImplement individualized HIV treatment regimens that meet the needs of diverse patient populations
I'm interested in this
Share with others
Write the first review
Share with others